Antiretroviral Drugs Impact Autophagy Differently in Primary Human Astrocytes
Cells · 01.12.2025 · 14 (23) · 1904
DOI: 10.3390/cells14231904 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 01.12.2025. Verfasst von Laura Cheney und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Hauptthemen laut MEDLINE: Astrocytes, Autophagy, Anti-Retroviral Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health National Institute on Aging, National Institutes of Health National Institute on Drug Abuse, National Institutes of Health National Institute on Mental Health.
Abstract (Originalsprache)
While antiretroviral therapy (ART) has significantly improved the morbidity of HIV infection, ART may contribute to the pathogenesis of HIV associated neurocognitive impairment (HIV-NCI) by interfering with autophagic processes in astrocytes. Autophagy and mitophagy remove unwanted/damaged material and mitochondria from the intracellular environment, respectively. Dysregulated autophagy in astrocytes, abundant CNS cells with crucial homeostatic functions, contributes to many neurodegenerative diseases. Few studies have examined effects of ART on autophagy in astrocytes. We treated primary human astrocytes with a common ART regimen and performed LC3B-II and p62 turnover assays. ART significantly inhibited both LC3B-II and p62 turnover. Since p62, one autophagy receptor that mediates mitophagy, autophagic clearance of mitochondria, turnover was inhibited, we also examined mitophagy. While ART decreased BNIP3L/Nix homodimers, there were no changes in PINK1, Parkin, Mt-CO2, mitochondrial mass, or mitochondria–lysosome colocalization, indicating that ART did not inhibit mitophagy. We show that antiretroviral drugs have distinct effects on autophagic processes in astrocytes, which represents an alteration in their homeostasis, a major function of autophagy. This likely contributes to HIV-NCI. Understanding these impacts is important for improving ART for PWH, who have, by necessity, ongoing ART exposure. It also facilitates development of therapies for HIV-NCI that may include modulation of autophagy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Infectious Diseases, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- Analytical Imaging Facility, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
ORCID-Profile: Laura Cheney
Förderung
- National Institutes of Health National Institute on Aging
- National Institutes of Health National Institute on Drug Abuse
- National Institutes of Health National Institute on Mental Health
- National Institutes of Health National Cancer Institute
- NIA NIH HHS
- NIAID NIH HHS
- NIMH NIH HHS
- NIH HHS
Zitieren
APA
Cheney, L., McDermott, G., Guzik, H., & Berman, J. W. (2025). Antiretroviral Drugs Impact Autophagy Differently in Primary Human Astrocytes. Cells, 14(23), 1904. https://doi.org/10.3390/cells14231904
Vancouver
Cheney L, McDermott G, Guzik H, Berman JW. Antiretroviral Drugs Impact Autophagy Differently in Primary Human Astrocytes. Cells. 2025;14(23):1904. doi:10.3390/cells14231904
BibTeX
@article{Cheney2025,
author = {Cheney, Laura and McDermott, Grace and Guzik, Hillary and Berman, Joan W},
title = {Antiretroviral Drugs Impact Autophagy Differently in Primary Human Astrocytes},
journal = {Cells},
year = {2025},
volume = {14},
number = {23},
pages = {1904},
doi = {10.3390/cells14231904}
}
EUVIMED